The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis

Even though S-1 is a widely used chemotherapeutic agent, there is no evidence for its use in an adjuvant setting for biliary tract carcinoma (BTC). Patients who underwent surgical treatment for BTC between August 2007 and December 2018 were selected. Propensity score matching was performed between p...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Yoichi, Kogure, Ryota, Nakazawa, Akiko, Nagata, Rihito, Mitsui, Tetsuya, Ninomiya, Riki, Komagome, Masahiko, Maki, Akira, Kawarabayashi, Nobuaki, Beck, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957643/
https://www.ncbi.nlm.nih.gov/pubmed/33804297
http://dx.doi.org/10.3390/jcm10050925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957643/
https://www.ncbi.nlm.nih.gov/pubmed/33804297
http://dx.doi.org/10.3390/jcm10050925

Ejemplares similares